The bashing continues on the Seeking Alpha comments section

New Post Public Reply Private Reply Replies (4) Message Board
Drano
The bashing continues on the Seeking Alpha comments section from the lastest article. Here's what one basher says:


Quote:
The percentage of Phase II trials that proceed to Phase III, as of 2008, is 18%.


and here's my response.


Remember Mark Twain's famous line? "There are 3 kinds of lies: lies, damn lies, and statistics." The FDA approval rate for a drug that is safe and effective approaches 100%. You're basing your statistical claims on a false premise. It doesn't matter how many drugs fail when they aren't safe and effective -- what matters is the likelihood that the drug in question will be approved. For example, if less than 1% of college football players end up with a professional football career, does that mean that NO ONE succeeds in becoming a professional player? No, it does not. The statistical incidence of failure does not affect the success of the best players.

All drugs in clinical trials and all clinical trial designs are not equal. By understanding the science and the progress of the clinical trials an astute observer can determine much more logical estimates of the chance of success. So far all of CTIX's clinical trials have been successful. There have been no serious side effects, and there are signs of efficacy. If you investigated the scientific progress so far, the mechanism of action of the drugs, the pre-clinical animal studies, and the clinical trial design for these specific investigational drugs, you might also see why so many astute investors are excited by these drugs.

You also quote a statistic from 2008. Perhaps you are unaware that in the past 8 years, the FDA has made some significant changes in the way they review drugs, and researchers have become more sophisticated in trial design and selection of which drugs to send through the approval process. Your statistic about trial success or failure in 2008 has very little to do with the chance of success for CTIX's pipeline in 2016 -- especially given that several of the drugs CTIX is studying are first-in-class. For instance, currently there is NO FDA-approved drug for oral mucositis. The chance of approval is very, very high for a drug that offers relief for some patients who suffer from this condition. Likewise, the chance of approval for CTIX's one-dose antibiotic from an entirely new class of antibiotics (at a time when there are grave concerns about antibiotic resistance world-wide) is much higher than the chance of approval for, say, a new cholesterol drug or other less urgent need.

If it were possible to separate out the approval rate for drugs that have received QIDP status or orphan drug status from the FDA (as some of CTIX's drugs have), and to see a statistic about approval rates for these sub-categories of drugs from the past couple of years, I'd pay some attention to such a statistic. But in this case, your statistic is definitely in Mark Twain's Category 3.

Astute investors will not be scared by bogus statistics.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fervo’s 46% Slide Puts Geothermal Claims Under Fire

Updated Category News Views 162

A 46% haircut from an IPO price has a way of stripping the paint off a growth story. Fervo Energy closed at $14.33 after the October 6 report cited in Hagens Berman’s announcement, well below its $27 IPO price from last May. That does not prove the report is right. It does mean NASDAQ:FRVO investors are staring at questions that go straight to the economic spine of...

Continue Reading
Five SEAL Medal of Honor Signatures, One Charity Lot

Updated Category News Views 74

A single rifle can carry a staggering amount of meaning when the names on it belong to all five living U.S. Navy SEAL Medal of Honor recipients. Rock Island Auction Company plans to offer that one-of-a-kind custom precision rifle during its December 4–6, 2026 Premier Firearms Auction, and the financial arrangement is unusually clean: 100% of proceeds are slated for the...

Continue Reading
COP31 Tests Whether Climate Warnings Move Power Systems

Updated Category News Views 101

A weather alert that never reaches the control room is just expensive wallpaper. That was the useful, unsentimental thread running through a COP31 side event in Ankara on November 13: climate diplomacy is not worth much if grid operators, project owners and financiers do not change what they do when the forecast turns ugly. Implementation Means Changing Operations COP31...

Continue Reading
Lieda Shadwick’s Career Education Work Earns 2026 Honor

Updated Category News Views 76

Twenty-six years in classrooms is not the sort of accomplishment that needs fireworks to carry weight. Lieda A. Shadwick’s recognition as The Inner Circle’s 2026 Educator of the Year points to a career built around a stubbornly important idea: students need more than academic vocabulary if they are going to navigate work, leadership, and business with any confidence....

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 15

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 54

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
SKINformed Bets on Skin Longevity Over Quick Fixes

Updated Category News Views 95

Wrinkle panic has been a very profitable racket for a long time, and SKINformed is trying to sidestep it. The physician-founded skincare brand is planting its flag on “SKINgevity,” a term it uses to describe long-term skin health rather than a frantic hunt for an overnight rewind. That is a sensible read on where beauty consumers appear to be headed: less appetite for...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 65

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Zensar’s AI Forum Puts Operations Before the AI Hype

Updated Category News Views 47

Johannesburg’s AI conversation seems to be shedding its costume jewelry at last. Zensar’s invitation-only CIS Converge 2026 forum, held on November 20, put the attention where it belongs: not on breathless demos, but on whether companies can turn AI into sturdier operations, better customer experiences, and something resembling a measurable return. That is a healthier...

Continue Reading
Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 6

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading

Top 5 Most Recently Viewed Articles

Sienna Senior Living Closes Successful Common Share Offering

Updated Category News Views 138

Sienna Senior Living Completes Successful Common Share Offering Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX:SIA) has successfully concluded a significant offering of common shares, raising approximately $144 million in gross proceeds. This achievement highlights the Company’s strong position within the senior living industry, supported by its...

Continue Reading
Discover the Richness of Japan's Honkaku Shochu in LA

Updated Category News Views 248

Shochu Rising 2025: A Celebration of Japan's Authentic Spirit The Japan Sake and Shochu Makers Association proudly presents Shochu Rising 2025, a two-day cultural event dedicated to Honkaku Shochu, Japan's exquisite distilled spirit. This celebration takes place in Los Angeles, bridging the gap between Japanese distillers and U.S. culinary professionals, media, and...

Continue Reading
Discover Unique Halloween Airblown Inflatables for Your Home

Updated Category News Views 206

Transform Your Home This Halloween with Stunning Inflatables Prepare to wow your guests and trick-or-treaters with an impressive array of Halloween decorations! This season, Gemmy has unveiled five unique Airblown Inflatables, each crafted to bring an eerie yet welcoming atmosphere to your yard. LightShow Airblown Inflatables This season, make a memorable impression with...

Continue Reading
Teamsters Unite Allegiant Air Pilots for Fair Contract Picket

Updated Category News Views 268

Allegiant Air Pilots Preparing for Nationwide Picket Teamsters Demand Fair Contract Covering 1,400 Workers Allegiant Air pilots, represented by Teamsters Local 2118, are set to hold a nationwide picket to voice their demand for a fair contract. This protest is scheduled for November 18, and it aims to address ongoing negotiation delays that have caused frustration among...

Continue Reading
Latest Earnings Insights from John Hancock Closed-End Funds

Updated Category News Views 171

Financial Highlights from John Hancock Closed-End Funds The John Hancock Closed-End Funds have recently announced their earnings for the last quarter, providing valuable insights for investors. This data sheds light on their financial position as of December 31, the comparison to the previous fiscal year gives a clearer picture of growth and performance. Understanding...

Continue Reading